| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |